首页> 美国卫生研究院文献>Experimental Diabetes Research >Levels of Inflammatory Cytokines IL-1β IL-6 IL-8 IL-17A and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy
【2h】

Levels of Inflammatory Cytokines IL-1β IL-6 IL-8 IL-17A and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy

机译:糖尿病性视网膜病变患者水液中炎性细胞因子IL-1βIL-6IL-8IL-17A和TNF-α的水平

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetic retinopathy is the leading cause of blindness in working age individuals in developed countries. However, the role of inflammation in the pathogenesis of DR is not completely understood. This is an observational clinical research enrolling 80 type II diabetic patients who had undergone cataract surgeries either with DR or without DR. All cases were further categorized by the proliferative stages of retinal neovascularization and by the lengths of diabetic history. The levels of inflammatory cytokines including IL-1β, IL-6, IL-8, IL-17, and TNF-α in aqueous humour were tested. Results in this study indicated that these cytokine levels were increased in DR patients and might have a synergistic effect on the pathogenesis of this disease. They were also elevated along with the progression of neovascularization, reflecting the severity of DR. The results also suggested that for diabetic patients, the higher these levels are, the sooner retinal complications might appear. In conclusion, the levels of inflammatory cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in aqueous humour may be associated with the pathogenesis, severity, and prognosis of DR.
机译:糖尿病性视网膜病是发达国家劳动年龄人群失明的主要原因。然而,炎症在DR的发病机理中的作用尚不完全清楚。这是一项观察性临床研究,纳入了80例接受DR或不进行DR的白内障手术的II型糖尿病患者。根据视网膜新血管形成的增生阶段和糖尿病史的长短对所有病例进行进一步分类。测试房水中包括IL-1β,IL-6,IL-8,IL-17和TNF-α在内的炎性细胞因子的水平。这项研究的结果表明,DR患者中这些细胞因子水平升高,可能对这种疾病的发病机理具有协同作用。随着新血管形成的进展,它们也升高,反映了DR的严重性。结果还表明,对于糖尿病患者,这些水平越高,视网膜并发症可能越早出现。总之,房水中炎性细胞因子IL-1β,IL-6,IL-8,IL-17A和TNF-α的水平可能与DR的发病机理,严重程度和预后有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号